Skip to main content
. 2014 Oct 24;33(1):425–432. doi: 10.3892/or.2014.3569

Figure 4.

Figure 4

CD271+ cells possess the ability to resist to conventional chemotherapeutic reagents in vitro. Surviving cells were detected in sorted CD271+ and CD271 cells treated with (A) DDP and (B) 5-FU by CCK8 assay. CD271 expression was analyzed in (D and F) DDP-, (E and G) 5-FU-resistant cells and (C) parent cells by flow cytometry.